Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial
Key facts
- Who runs it
- The University of Queensland
- Where
- Australia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- Jun 2026
- Expected to end
- Feb 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- ClearGuard HD
- B Braun Combi-stopper
- Record updated
- 29 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age≥18
- Able to provide informed consent
- Kidney failure requiring a tunnelled CVC for treatment (haemodialysis)
- 21 days BSI free
- No known allergy to chlorhexidine and/or nylon and/or polypropylene
Who cannot take part
- Known allergic to chlorhexidine and/or nylon and/or polypropylene
- People with a cognitive impairment and/or intellectual disability
- Current CLABSI
- Patients on an end-of-life pathway
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to compare a chlorhexidine antimicrobial barrier cap in patients requiring hemodialysis treatment to the standard hemodialysis caps currently used within the Metro North Kidney Health Service.
Read full original descriptionShow less
The main questions to answer are:
* Study Feasibility * Occurrence of infectious complications related to renal central venous catheters
Participants will be randomly allocated to receive either of the below hemodialysis caps to cover their hemodialysis catheter hub:
* The standard hemodialysis cap used at the Royal Brisbane and Women's Hospital, or * The intervention hemodialysis cap containing chlorhexidine inside it
Researchers will compare standard and chlorhexidine hemodialysis caps to see if the presence of chlorhexidine improves the occurrance of infectious complications related to the hemodialysis catheter.
The 2 groups in the trial
- ControlExisting treatment, for comparison
Standard Non-Antimicrobial Hemodialysis Cap
Treatment: B Braun Combi-stopper
- InterventionTreatment being tested
Antimicrobial Haemodialysis Catheter Luer End Cap
Treatment: ClearGuard HD
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of Chlorhexidine Caps for Central Line Associated Blood Stream Infection Prevention in People Needing Hemodialysis: a Pilot Randomised Control Trial
- Record updated
- 29 April 2026